June 1, 2023
L’Oréal’s venture capital fund BOLD has made a minority investment in US-based biotech company Debut.
Debut specializes in the end-to-end discovery, formulation, clinical trial, and manufacture of new ingredients and products. L’Oréal says that Debut’s cell-free biomanufacturing...